Disease Management & Health Outcomes

, Volume 11, Issue 5, pp 337–344 | Cite as

Disease Management Update

From the World Literature


Chronic Obstructive Pulmonary Disease Metformin Bariatric Surgery Diabetic Retinopathy Usual Care 


2. Hospitalization Costs Not Reduced with Surgery in Obesity

  1. Ågren G, Narbro K, Jonsson E, et al. Cost of in-patient care over 7 years among surgically and conventionally treated obese patients. Obes Res Dec 2002; 10: 1276–83.PubMedCrossRefGoogle Scholar

3. Education Needed to Increase’ Flu Vaccination Rates Among Elderly

  1. Zimmerman RK, Santibanez TA, Janosky JE, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med Jan 2003; 114: 31–8.PubMedCrossRefGoogle Scholar

4. Hospitalist Care Reduces Resource Use, Costs in the US

  1. 1.
    Meltzer D, Manning WG, Morrison J, et al. Effects of physician experience on costs and outcomes on an academic general medicine service: results of a trial of hospitalists. Ann Int Med 3 Dec 2002; 137: 866–74.PubMedGoogle Scholar
  2. 2.
    American College of Physicians-American Society of Internal Medicine. The who, what, when, where, whom, and how of hospitalist care. Ann Int Med 3 Dec 2002; 137: 930–1.Google Scholar

5. Collaborative Care Intervention Warranted for Panic Disorder in the US

  1. Katon WJ, Roy-Byrne P, Russo J, et al. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psych Dec 2002; 59: 1098–1104.CrossRefGoogle Scholar

6. Home Hospitalization Cuts Costs in COPD

  1. Hernandez C, Casas A, Escarrabill J, et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Resp J Jan 2003; 21: 58–67.CrossRefGoogle Scholar

7. Cancer DM Program Saves US Millions in Third Year

  1. Quality oncology claims $4.3 million savings for Fla. plan. Dis Manage News 25 Feb 2003; 3 & 8.Google Scholar

8. Polio Vaccination “a Good Economic Investment”

  1. Khan MM, Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine Jan 2003; 21: 702–5.PubMedCrossRefGoogle Scholar

9. Drug Assistance Program Pays Off From Hospital Perspective

  1. Coleman CI, Reddy P, Quercia RA, et al. Cost-benefit analysis of a pharmacy-managed medication assistance program for hospitalized indigent patients. Am J Health Syst Pharm 15 Feb 2003; 60: 378–82.PubMedGoogle Scholar

10. Major Depression Increases Costs Among US Elderly with Diabetes

  1. Finkelstein EA, Bray JW, Chen H, et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diab Care Feb 2003; 26: 415–20.CrossRefGoogle Scholar

11. Camera-Based Screening for Diabetic Retinopathy Well Worth it in Canada

  1. Maberley D, Walker H, Koushik A, et al. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 21 Jan 2003; 168: 160–4.PubMedGoogle Scholar

12. Chemotherapy Use Diverges from US Breast Cancer Guidelines

  1. Du XL, Key CR, Osborne C, et al. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Int Med 21 Jan 2003; 138: 90–7.Google Scholar

13. Endoscopic Screening Worth It for Pancreatic Cancer in the US

  1. Rulyak SJ, Kimmey MB, Veenstra DL, et al. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc Jan 2003; 57: 23–9.PubMedCrossRefGoogle Scholar

14. Statins Underused for Stroke, TIA in Austria

  1. Lalouschek W, Lang W, Greisenegger S, et al. Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischrmic attack. Stroke Jan 2003; 34: 105–10.PubMedCrossRefGoogle Scholar

15. Health Interventions “Very Cost Effective” in Less-Developed Countries

  1. Murray CJL, Lauer JA, Hutubessy RCW, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 1 Mar 2003; 361: 717–25.PubMedCrossRefGoogle Scholar

16. Is DOTS-Plus Worth It for TB in Developing Countries?

  1. Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ 15 Mar 2003; 326: 574–7.PubMedCrossRefGoogle Scholar

17. Opioid Analgesics Underused for Neuropathic Pain in Canada

  1. Gilron I, Bailey JM. Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials. Can J Anaesth Jan 2003; 50: 42–7.PubMedCrossRefGoogle Scholar

18. Cost Analysis of Modest Interventions to Prevent Type 2 Diabetes

  1. 1.
    Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diab Care Jan 2003; 26: 36–47.Google Scholar
  2. 2.
    Teutsch S. The cost of preventing diabetes: what do we know and what do we need to know? Diab Care Jan 2003; 26: 238–9.CrossRefGoogle Scholar

19. Pharmacy Claims Data Improve Physician Quality of Care

  1. Bieszk N, Patel R, Heaberlin A, et al. Detection of medication nonadherence through review of pharmacy claims data. Am J Health Syst Pharm 15 Feb 2003; 60: 360–6.PubMedGoogle Scholar

20. Guideline Compliance Poor in Antipsychotic Prescribing

  1. Sernyak MJ, Dausey D, Desai R, et al. Prescribers’ nonadherence to treatment guidelines for schizophrenia when prescribing neuroleptics. Psychiatr Serv Feb 2003; 54: 246–8.PubMedCrossRefGoogle Scholar

21. Asthma Severity Underestimated, Treatment Suboptimal in the US

  1. Wolfenden LL, Diette GB, Krishnan JA, et al. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Int Med 27 Jan 2003; 163: 231–6.CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Personalised recommendations